Search research articles
Contact Us
Filters
Showing results (31-40 of 107) with videos related to
Page
of 11
Sort By:
The Review of Diabetic Studies : RDS
|
October 7, 2009
Type 1 diabetes development requires both CD4+ and CD8+ T cells and can be reversed by non-depleting antibodies targeting both T cell populations
Jenny M Phillips, Nicole M Parish, Tim Raine, et al.
Journal of Clinical Medicine
|
February 13, 2025
A Treat-to-Target Approach in IBD: Contemporary Real-World Perspectives from an International Survey
Mohmmed Tauseef Sharip, Biljana Brezina, Juan De La Revilla Negro, et al.
United European Gastroenterology Journal
|
March 5, 2026
Corticosteroid Use in Childhood-Onset Inflammatory Bowel Disease: A Nationwide Cohort Study (2006-2022)
Karl Mårild, Mikkel Malham, Petter Malmborg, et al.
American Journal of Physiology. Cell Physiology
|
October 20, 2025
Protease-activated receptor 1-mediated matrix metalloprotease signaling in sensory neurons
Katie J Williams, Giulia Galimberti, James P Higham, et al.
Journal of Comparative Effectiveness Research
|
February 24, 2025
Matching-adjusted indirect comparisons of efficacy outcomes between etrasimod and ozanimod for moderately to severely active ulcerative colitis
Vipul Jairath, Tim Raine, Thomas P Leahy, et al.
Journal of Comparative Effectiveness Research
|
March 17, 2025
Efficacy and safety of advanced therapies for moderately to severely active ulcerative colitis in induction and maintenance: systematic literature review and Bayesian network meta-analysis
Vipul Jairath, Tim Raine, Thomas P Leahy, et al.
Inflammatory Bowel Diseases
|
December 2, 2025
Clinical Response for 12 Months or More to the First Advanced Therapy is Associated with a Significant Decrease in the Long-Term Risk of Hospitalization: A Nation-Wide Analysis of Patients From the UK Inflammatory Bowel Disease (IBD) BioResource
Kaung Yan, Sudheer Kumar Vuyyuru, Adam Taylor, et al.
Journal of Crohn'S & Colitis
|
November 9, 2023
Impact of Baseline Corticosteroid Use on the Efficacy and Safety of Upadacitinib in Patients with Ulcerative Colitis: A Post Hoc Analysis of the Phase 3 Clinical Trial Programme
Tim Raine, Yoh Ishiguro, David T Rubin, et al.
Inflammatory Bowel Diseases
|
April 1, 2023
Endoscopic and Histological Placebo Rates in Crohn's Disease Clinical Trials: A Systematic Review and Meta-analysis
Sudheer K Vuyyuru, Tran M Nguyen, Malcolm Hogan, et al.
Journal of Crohn'S & Colitis
|
June 20, 2020
Faecal Biomarkers in Inflammatory Bowel Diseases: Calprotectin Versus Lipocalin-2-a Comparative Study
Andreas Zollner, Andreas Schmiderer, Simon J Reider, et al.
Page
of 11
Search research articles
Search
Showing results (31-40 of 107) with videos related to
Sort By:
Page
of 11
The Review of Diabetic Studies : RDS
|
October 7, 2009
Type 1 diabetes development requires both CD4+ and CD8+ T cells and can be reversed by non-depleting antibodies targeting both T cell populations
Jenny M Phillips, Nicole M Parish, Tim Raine, et al.
Journal of Clinical Medicine
|
February 13, 2025
A Treat-to-Target Approach in IBD: Contemporary Real-World Perspectives from an International Survey
Mohmmed Tauseef Sharip, Biljana Brezina, Juan De La Revilla Negro, et al.
United European Gastroenterology Journal
|
March 5, 2026
Corticosteroid Use in Childhood-Onset Inflammatory Bowel Disease: A Nationwide Cohort Study (2006-2022)
Karl Mårild, Mikkel Malham, Petter Malmborg, et al.
American Journal of Physiology. Cell Physiology
|
October 20, 2025
Protease-activated receptor 1-mediated matrix metalloprotease signaling in sensory neurons
Katie J Williams, Giulia Galimberti, James P Higham, et al.
Journal of Comparative Effectiveness Research
|
February 24, 2025
Matching-adjusted indirect comparisons of efficacy outcomes between etrasimod and ozanimod for moderately to severely active ulcerative colitis
Vipul Jairath, Tim Raine, Thomas P Leahy, et al.
Journal of Comparative Effectiveness Research
|
March 17, 2025
Efficacy and safety of advanced therapies for moderately to severely active ulcerative colitis in induction and maintenance: systematic literature review and Bayesian network meta-analysis
Vipul Jairath, Tim Raine, Thomas P Leahy, et al.
Inflammatory Bowel Diseases
|
December 2, 2025
Clinical Response for 12 Months or More to the First Advanced Therapy is Associated with a Significant Decrease in the Long-Term Risk of Hospitalization: A Nation-Wide Analysis of Patients From the UK Inflammatory Bowel Disease (IBD) BioResource
Kaung Yan, Sudheer Kumar Vuyyuru, Adam Taylor, et al.
Journal of Crohn'S & Colitis
|
November 9, 2023
Impact of Baseline Corticosteroid Use on the Efficacy and Safety of Upadacitinib in Patients with Ulcerative Colitis: A Post Hoc Analysis of the Phase 3 Clinical Trial Programme
Tim Raine, Yoh Ishiguro, David T Rubin, et al.
Inflammatory Bowel Diseases
|
April 1, 2023
Endoscopic and Histological Placebo Rates in Crohn's Disease Clinical Trials: A Systematic Review and Meta-analysis
Sudheer K Vuyyuru, Tran M Nguyen, Malcolm Hogan, et al.
Journal of Crohn'S & Colitis
|
June 20, 2020
Faecal Biomarkers in Inflammatory Bowel Diseases: Calprotectin Versus Lipocalin-2-a Comparative Study
Andreas Zollner, Andreas Schmiderer, Simon J Reider, et al.
Page
of 11